Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-07-27
1995-01-17
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 54, 514 61, 536118, 536120, 536121, A61K 3170, A61K 31715, C07H 1312, C07H 2300
Patent
active
053825705
ABSTRACT:
The invention relates to sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type, of which N-sulfate, N-acetate, and hydroxy groups, are replaced by alkoxy, aryloxy, aralkoxy, or O-sulfate groups. The compounds have antithrombotic and smooth muscle cell proliferation inhibiting activities.
REFERENCES:
patent: 3301848 (1967-01-01), Halleck
patent: 4105760 (1978-08-01), Szejtli et al.
patent: 4221907 (1980-09-01), Nair et al.
patent: 4818816 (1989-04-01), Petitou et al.
patent: 4841041 (1989-06-01), van Boeckel et al.
Cancer Research, vol. 49, issued Aug. 1, 1989, Tietze et al, "Proton-Mediated Liberation of Aldophamide from a Nontoxic Prodrug: A Strategy for Tumor-Selective Activation of Cytocidal Drugs", pp. 4179-4184.
Petitou Maurice
van Boeckel Constant A. A.
Akzo N.V.
Blackstone William M.
Gormley Mary E.
Rollins John W.
Snofi, S.A.
LandOfFree
Sulfated glycosaminoglycanoid derivatives of the dermatan sulfat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfated glycosaminoglycanoid derivatives of the dermatan sulfat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfated glycosaminoglycanoid derivatives of the dermatan sulfat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-747174